Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinnarizine plus propranolol versus placebo plus propranolol for pediatric migraine
IRCT20180724040576N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in pediatric migraine comparing Propranolol + cinnarizine with Propranolol + placebo (2 arms). Primary endpoints: Frequency of migraine headaches and Severity of migraine headaches. Started Nov 2018; status: completed.
02
Drugs
cinnarizinepropranolol
03
Conditions
pediatric migraine
Beyond the preview
Go deeper on IRCT20180724040576N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180724040576N1.